Glancy prongay & murray llp reminds investors of looming deadline in the class action lawsuit against nrx pharmaceuticals, inc. (nrxp)

Los angeles--(business wire)--glancy prongay & murray llp (“gpm”) reminds investors of the upcoming march 21, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired nrx pharmaceuticals, inc. (“nrx” or the “company”) (nasdaq: nrxp) securities between june 1, 2021 and november 4, 2021, inclusive (the “class period”). if you suffered a loss on your nrx investments or would like to inquire about potentially pursuing cla
NRXP Ratings Summary
NRXP Quant Ranking